NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacyTakahiro Miyazaki, Jonathan Zalevsky, Joanna Wilczek et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 55
NKTR-358: A novel regulatory T-cell stimulator that selectively stimulates expansion and suppressive function of regulatory T cells for the treatment of autoimmune and inflammatory diseasesNeha Dixit, Jonathan Zalevsky, Christie Fanton et al.|Journal of Translational Autoimmunity|2021Cited by 54
Abstract 3755: Comprehensive antitumor immune activation by a novel TLR7/8 targeting agent NKTR-262 combined with CD122-biased immunostimulatory cytokine NKTR-214Saul Kivimäe, Jonathan Zalevsky, Marlene Hennessy et al.|Cancer Research|2018Cited by 19
Immune memory in nonclinical models after treatment with NKTR-214, an engineered cytokine biased towards expansion of CD8+ T cells in tumor.Deborah H. Charych, Jonathan Zalevsky, Vidula Dixit et al.|Journal of Clinical Oncology|2016Cited by 1